173 related articles for article (PubMed ID: 31689275)
41. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
[TBL] [Abstract][Full Text] [Related]
42. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
[TBL] [Abstract][Full Text] [Related]
43. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
[TBL] [Abstract][Full Text] [Related]
44. Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).
Marega LF; Teocchi MA; Dos Santos Vilela MM
Clin Exp Immunol; 2016 Aug; 185(2):148-53. PubMed ID: 27060458
[TBL] [Abstract][Full Text] [Related]
45. Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma.
van den Berg A; Maggio E; Diepstra A; de Jong D; van Krieken J; Poppema S
Blood; 2002 Feb; 99(4):1492-4. PubMed ID: 11830507
[TBL] [Abstract][Full Text] [Related]
46. A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect.
Simesen de Bielke MG; Yancoski J; Rocco C; Pérez LE; Cantisano C; Pérez N; Oleastro M; Danielian S
J Clin Immunol; 2012 Dec; 32(6):1197-203. PubMed ID: 22752343
[TBL] [Abstract][Full Text] [Related]
47. IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome.
Niss O; Sholl A; Bleesing JJ; Hildeman DA
J Allergy Clin Immunol; 2015 Mar; 135(3):762-70. PubMed ID: 25174872
[TBL] [Abstract][Full Text] [Related]
48. Tubulointerstitial nephritis in a patient with probable autoimmune lymphoproliferative syndrome.
Glerup M; Herlin T; Rittig S; Grønbæk K; Hokland M; Hasle H
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e187-9. PubMed ID: 23588339
[TBL] [Abstract][Full Text] [Related]
49. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Magerus-Chatinet A; Neven B; Stolzenberg MC; Daussy C; Arkwright PD; Lanzarotti N; Schaffner C; Cluet-Dennetiere S; Haerynck F; Michel G; Bole-Feysot C; Zarhrate M; Radford-Weiss I; Romana SP; Picard C; Fischer A; Rieux-Laucat F
J Clin Invest; 2011 Jan; 121(1):106-12. PubMed ID: 21183795
[TBL] [Abstract][Full Text] [Related]
50. Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.
Agrebi N; Ben-Mustapha I; Matoussi N; Dhouib N; Ben-Ali M; Mekki N; Ben-Ahmed M; Larguèche B; Ben Becher S; Béjaoui M; Barbouche MR
Clin Immunol; 2017 Oct; 183():17-23. PubMed ID: 28668589
[TBL] [Abstract][Full Text] [Related]
51. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study.
Seif AE; Manno CS; Sheen C; Grupp SA; Teachey DT
Blood; 2010 Mar; 115(11):2142-5. PubMed ID: 20068224
[TBL] [Abstract][Full Text] [Related]
52. 18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
Wong KK; Sedig LK; Bloom DA; Hutchinson RJ; Shulkin BL
Pediatr Radiol; 2020 Apr; 50(4):524-533. PubMed ID: 31776602
[TBL] [Abstract][Full Text] [Related]
53. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.
Janda A; Schwarz K; van der Burg M; Vach W; Ijspeert H; Lorenz MR; Elgizouli M; Pieper K; Fisch P; Hagel J; Lorenzetti R; Seidl M; Roesler J; Hauck F; Traggiai E; Speckmann C; Rensing-Ehl A; Ehl S; Eibel H; Rizzi M
Blood; 2016 May; 127(18):2193-202. PubMed ID: 26907631
[TBL] [Abstract][Full Text] [Related]
54. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
Takagi M; Shinoda K; Piao J; Mitsuiki N; Takagi M; Matsuda K; Muramatsu H; Doisaki S; Nagasawa M; Morio T; Kasahara Y; Koike K; Kojima S; Takao A; Mizutani S
Blood; 2011 Mar; 117(10):2887-90. PubMed ID: 21063026
[TBL] [Abstract][Full Text] [Related]
55. The genetic landscape of the FAS pathway deficiencies.
Magerus A; Bercher-Brayer C; Rieux-Laucat F
Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
[TBL] [Abstract][Full Text] [Related]
56. Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS).
Ucar D; Kim JS; Bishop RJ; Nussenblatt RB; Rao VK; Sen HN
Ocul Immunol Inflamm; 2017 Oct; 25(5):703-709. PubMed ID: 27229379
[TBL] [Abstract][Full Text] [Related]
57. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Magerus-Chatinet A; Stolzenberg MC; Lanzarotti N; Neven B; Daussy C; Picard C; Neveux N; Desai M; Rao M; Ghosh K; Madkaikar M; Fischer A; Rieux-Laucat F
J Allergy Clin Immunol; 2013 Feb; 131(2):486-90. PubMed ID: 22857792
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.
Lambotte O; Neven B; Galicier L; Magerus-Chatinet A; Schleinitz N; Hermine O; Meyts I; Picard C; Godeau B; Fischer A; Rieux-Laucat F
Haematologica; 2013 Mar; 98(3):389-92. PubMed ID: 22983577
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
Zhang Q; Tian T; Wang L; Qiu H; Li D
Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
[TBL] [Abstract][Full Text] [Related]
60. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
Li P; Huang P; Yang Y; Hao M; Peng H; Li F
Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]